Copyright
©The Author(s) 2025.
World J Stem Cells. Jun 26, 2025; 17(6): 106272
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.106272
Published online Jun 26, 2025. doi: 10.4252/wjsc.v17.i6.106272
Figure 1 Isolation, culture, identification, and induced differentiation of human umbilical cord mesenchymal stem cells.
A: On day 15 of primary cell culture, human umbilical cord mesenchymal stem cells exhibited robust growth and over 90% confluence (magnification 100 ×); B: Identification of human umbilical cord mesenchymal stem cell surface antigens by flow cytometry; C: Induction of chondroblastic differentiation for three weeks resulted in the appearance of chondrocytes that stained blue with Alcian Blue (magnification 50 ×); D: Induction of adipogenic differentiation for two weeks resulted in the appearance of lipid droplets that stained red with Oil Red O (magnification 200 ×); E: Induction of osteogenic differentiation for three weeks led to the appearance of calcium nodules that stained red with Alizarin Red (magnification 100 ×).
Figure 2 Transmission electron microscopy images of platelets in the different groups.
A: Platelet morphology in the low-altitude group; B: Platelet morphology in the high-altitude group; C: Platelet morphology in the human umbilical cord mesenchymal stem cell group.
Figure 3 Expression levels of von Willebrand factor, platelet factor 4, and beta-thromboglobulin.
A: Expression of von Willebrand factor in the different groups; B: Expression of platelet factor 4 in the different groups; C: Expression of beta-thromboglobulin in the different groups. n = 8 in each group. aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.0001. vWF: von Willebrand factor; hUC-MSC: Human umbilical cord mesenchymal stem cell; PF4: Platelet factor 4; β-TG: Beta-thromboglobulin.
Figure 4 Expression of CD62p on platelet surfaces, as shown by flow cytometry.
A: The expression rate of CD62p in the low-altitude group was 14.3%; B: The expression rate of CD62p in the high-altitude group was 20.1%; C: The expression rate of CD62p in the human umbilical cord mesenchymal stem cell group was 14.4%; D: The expression rate of CD62p in low-altitude group, high-altitude group, and human umbilical cord mesenchymal stem cell group. n = 8 in each group. dP < 0.0001. hUC-MSC: Human umbilical cord mesenchymal stem cell.
Figure 5 Human umbilical cord mesenchymal stem cells reduce the release of platelet α-granules in rats exposed to acute high-altitude hypoxia via the protein kinase B/mitogen-activated protein kinase/extracellular-signal regulated kinase pathway.
A: Expression of p-protein kinase B in the different groups; B: Expression of p-mitogen-activated protein kinase in the different groups; C: Expression of p-extracellular-signal regulated kinase in the different groups. aP < 0.05, bP < 0.01, cP < 0.001. AKT: Protein kinase B; MEK: Mitogen-activated protein kinase; ERK: Extracellular-signal regulated kinase; hUC-MSC: Human umbilical cord mesenchymal stem cell.
- Citation: Zhang B, Gao BD, Su Y, Mi WJ, Zeng TX, Ma FF, Ha XQ. Human umbilical cord mesenchymal stem cells reduce platelet α-granule release in rats via the AKT/MEK/ERK pathway during acute exposure to high-altitude hypoxia. World J Stem Cells 2025; 17(6): 106272
- URL: https://www.wjgnet.com/1948-0210/full/v17/i6/106272.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i6.106272